The first non-surgical, AI-driven treatment that restores near vision — permanently.
Presbyopia — the gradual loss of near-focus after 40 — affects 1.8 billion people. Ocuvance targets the ciliary muscle directly, using precision bio-stimulation to restore elasticity that reading glasses merely compensate for.
Learn More